Evidence map›Paper›PMID 34079028›Full record

ArticleScientific reports2021

Focused peptide library screening as a route to a superior affinity ligand for antibody purification.

Krištof Bozovičar, Barbara Jenko Bizjan, Anže Meden, Jernej Kovač, Tomaž Bratkovič

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Krištof BozovičarFaculty of Pharmacy, Department of Pharmaceutical Biology, University of Ljubljana, Aškerčeva 7, 1000, Ljubljana, Slovenia.
Barbara Jenko BizjanClinical Institute of Special Laboratory Diagnostics, University Medical Center, University Children's Hospital, Vrazov trg 1, Ljubljana, Slovenia.
Anže MedenFaculty of Pharmacy, Department of Pharmaceutical Chemistry, University of Ljubljana, Aškerčeva 7, 1000, Ljubljana, Slovenia.
Jernej KovačClinical Institute of Special Laboratory Diagnostics, University Medical Center, University Children's Hospital, Vrazov trg 1, Ljubljana, Slovenia.
Tomaž BratkovičFaculty of Pharmacy, Department of Pharmaceutical Biology, University of Ljubljana, Aškerčeva 7, 1000, Ljubljana, Slovenia. tomaz.bratkovic@ffa.uni-lj.si.
University of Ljubljana · SILjubljana University Medical Centre · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Affinity chromatography is the linchpin of antibody downstream processing and typically relies on bacterial immunoglobulin (Ig)-binding proteins, epitomized by staphylococcal protein A-based ligands. However, such affinity ligands are fairly costly and suffer from chemical instability, leading to ligand denaturation and leaching from chromatographic support. Innovations in this area are aimed at developing robust and highly selective antibody ligands capable of withstanding harsh column sanitization conditions. We report the development and first-stage characterization of a selective short linear peptide ligand of the IgG Fc region capable of capturing all four IgG subclasses. The ligand was discovered through in vitro directed evolution. A focused phage-display library based on a previously identified peptide lead was subjected to a single-round screen against a pool of human IgG. The hits were identified with next-generation sequencing and ranked according to the enrichment ratio relative to their frequency in the pre-screened library. The top enriched peptide GSYWYNVWF displaying highest affinity for IgG was coupled to bromohydrin-activated agarose beads via a branched linker. The resulting affinity matrix was characterized with a dynamic binding capacity of approx. 43 mg/mL, on par with commercially employed protein A-based resin.

Indexed as

Peptide LibraryAlcoholsAmino Acid SequenceChromatography, AffinityDirected Molecular EvolutionHigh-Throughput Nucleotide SequencingHigh-Throughput Screening AssaysHumansImmunoglobulin Fc FragmentsImmunoglobulin GLigandsProtein BindingSepharoseStaphylococcal Protein AAlcoholsbromohydrinsImmunoglobulin Fc FragmentsImmunoglobulin GLigandsPeptide LibrarySepharoseStaphylococcal Protein A

Identifiers

PMID34079028
PMCPMC8173005
OpenAlexW3165331107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.